EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
3.1.1.25 | 1,4-lactonase |
macrophage |
- |
692438 |
2.3.1.23 | 1-acylglycerophosphocholine O-acyltransferase |
macrophage |
- |
704461, 736546, 756102 |
2.3.1.23 | 1-acylglycerophosphocholine O-acyltransferase |
macrophage |
primary peripheral blood macrophages |
735571 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
- |
650339, 652685, 678390, 690321, 690322, 690673, 691653, 691929, 693526 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
decidual and monocyte-derived |
650326 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
increased enzyme expression in artheriosclerosis |
650932 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
no significant modifications of pPAF-AH mRNA in macrophages or in ApoB100 values is observed in hepatitis C virus patients compared with controls |
681670 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
peritoneal |
650326 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
resident ones of the liver, and peritoneal |
652009 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
secretion |
649802 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
macrophage |
secretion of plasma isozyme after cleavage of the signal peptide at Ala17/Val18, high enzyme activity during differentiation of monocytes to macrophages |
653695 |
2.3.1.67 | 1-alkylglycerophosphocholine O-acetyltransferase |
macrophage |
- |
736604 |
2.3.1.67 | 1-alkylglycerophosphocholine O-acetyltransferase |
macrophage |
bone marrow-derived |
735644 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
macrophage |
activity occurs after differentiation of neutrophils to macrophages |
669730 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
macrophage |
derived from bone-marrow, peritoneal macrophages, expression of isozyme 11beta-HSD1, not isozyme 11beta-HSD2 |
669730 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
macrophage |
isoform 11betaHSD2 |
741066 |
1.14.14.29 | 25/26-hydroxycholesterol 7alpha-hydroxylase |
macrophage |
bone marrow-derived |
699414 |
3.1.4.53 | 3',5'-cyclic-AMP phosphodiesterase |
macrophage |
PDE4B. Ablation of PDE4B partially protects mice from LPS-induced shock |
669723 |
1.3.1.21 | 7-dehydrocholesterol reductase |
macrophage |
- |
763129 |
3.1.3.2 | acid phosphatase |
macrophage |
- |
134784, 652665, 666100, 679089 |
3.1.3.2 | acid phosphatase |
macrophage |
isozyme 5a, secretion |
665956 |
3.1.1.23 | acylglycerol lipase |
macrophage |
- |
751669 |
3.1.1.77 | acyloxyacyl hydrolase |
macrophage |
- |
246553 |
3.4.24.86 | ADAM 17 endopeptidase |
macrophage |
- |
638980, 639001, 639002, 639013, 681031 |
3.4.24.B28 | ADAM15 |
macrophage |
- |
733818 |
3.4.24.B9 | ADAM9 endopeptidase |
macrophage |
in advanced human atherosclerotic plaques of aorta and carotid and femoral arteries, high expression level |
710868 |
3.4.24.82 | ADAMTS-4 endopeptidase |
macrophage |
- |
677894, 679302 |
3.4.24.B11 | ADAMTS1 endopeptidase |
macrophage |
- |
669350, 755146 |
3.4.24.B11 | ADAMTS1 endopeptidase |
macrophage |
macrophages at sites of muscle injury induce activation of satellite cells via expression of Adamts1 |
754846 |
2.7.7.96 | ADP-D-ribose pyrophosphorylase |
macrophage |
- |
684834 |
1.1.1.21 | aldose reductase |
macrophage |
- |
-, 669503, 738833, 739113 |
1.1.1.21 | aldose reductase |
macrophage |
in inflamed temporal arteries |
668868 |
1.14.16.5 | alkylglycerol monooxygenase |
macrophage |
- |
746303 |
3.4.17.23 | angiotensin-converting enzyme 2 |
macrophage |
- |
679704, 681180, 708649 |
3.6.1.5 | apyrase |
macrophage |
- |
-, 756375 |
1.13.11.31 | arachidonate 12-lipoxygenase |
macrophage |
- |
-, 704947, 726846, 741573 |
1.13.11.31 | arachidonate 12-lipoxygenase |
macrophage |
12/15-LOX is a macrophage-selective regulator of interleukin-12 production |
-, 704003 |
1.13.11.31 | arachidonate 12-lipoxygenase |
macrophage |
12/15-LOX is expressed by 95% of resident peritoneal CD11bhigh cells, with the remaining 5% being 12/15-LOX-. 12/15-LOX+ cells are phenotypically defined by high F4/80, SR-A, and Siglec1 expression, and enhanced IL-10 and G-CSF generation. In contrast, 12/15-LOX- cells are a dendritic cell population. Resident peritoneal macrophage numbers are significantly increased in 12/15-LOX-/- mice, suggesting alterations in migratory trafficking or cell differentiation in vivo |
-, 704943 |
1.13.11.31 | arachidonate 12-lipoxygenase |
macrophage |
macrophages that overexpress 12/15LO have reduced ATP-binding cassette G1 expression, increased transporter phosphorylation, and reduced cholesterol efflux |
704567 |
1.13.11.31 | arachidonate 12-lipoxygenase |
macrophage |
peritoneal |
-, 684803 |
1.13.11.31 | arachidonate 12-lipoxygenase |
macrophage |
resident peritoneal |
742000 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
- |
703628, 742239 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
12/15-LOX is a macrophage-selective regulator of interleukin-12 production |
-, 704003 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
12/15-LOX is expressed by 95% of resident peritoneal CD11bhigh cells, with the remaining 5% being 12/15-LOX-. 12/15-LOX+ cells are phenotypically defined by high F4/80, SR-A, and Siglec1 expression, and enhanced IL-10 and G-CSF generation. In contrast, 12/15-LOX- cells are a dendritic cell population. Resident peritoneal macrophage numbers are significantly increased in 12/15-LOX-/- mice, suggesting alterations in migratory trafficking or cell differentiation in vivo |
-, 704943 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
alveolar |
742613 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
high level expression in peritoneal macrophages, while murine peripheral monocytes, alveolar macrophages and bone marrow-derived macrophages express alox15 only at low levels |
742613 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
isozyme 15-LO-1, differentiated monocytes obtained from human venous blood, CD14+ |
687235 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
peritoneal |
-, 684350 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
resident peritoneal |
742000 |
1.13.11.33 | arachidonate 15-lipoxygenase |
macrophage |
rheumatoid arthritis tissue |
701978 |
1.13.11.34 | arachidonate 5-lipoxygenase |
macrophage |
- |
660111, 704997, 711100, 713540, 743614 |
1.13.11.34 | arachidonate 5-lipoxygenase |
macrophage |
alveolar macrophage |
742001 |
3.5.3.1 | arginase |
macrophage |
- |
684384, 688998, 689301 |
3.5.3.1 | arginase |
macrophage |
alveolar macrophage |
667160, 686562 |
3.5.3.1 | arginase |
macrophage |
cultured head-kidney derived macrophages, significant enzyme activity, inhibitable by Nomega-hydroxy-L-arginine and induced by dibutyryl cyclic adenosine |
670294 |
3.5.3.1 | arginase |
macrophage |
cultured head-kidney derived macrophages, significant enzyme activity, inhibitable by Nomega-hydroxy-L-arginine, not inducible by dibutyryl cyclic adenosine |
670294 |
3.5.3.1 | arginase |
macrophage |
type I |
701646 |
4.1.1.28 | aromatic-L-amino-acid decarboxylase |
macrophage |
- |
705269 |
3.1.1.2 | arylesterase |
macrophage |
- |
692438 |
3.1.6.1 | arylsulfatase (type I) |
macrophage |
- |
709806 |
7.2.1.3 | ascorbate ferrireductase (transmembrane) |
macrophage |
- |
744757 |
3.5.1.15 | aspartoacylase |
macrophage |
resident peritoneal |
734393 |
2.3.3.8 | ATP citrate synthase |
macrophage |
- |
735597 |
2.7.11.15 | beta-adrenergic-receptor kinase |
macrophage |
- |
-, 673187 |
2.7.11.15 | beta-adrenergic-receptor kinase |
macrophage |
peritoneal macrophages, activation of Toll-like receptors significantly increases GRK2 expression in primary macrophages, mechanism, overview |
-, 689035 |
2.4.3.1 | beta-galactoside alpha-(2,6)-sialyltransferase |
macrophage |
- |
722730 |
2.4.1.38 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase |
macrophage |
high expression level |
687078 |
3.2.1.52 | beta-N-acetylhexosaminidase |
macrophage |
the importance of beta-hexosaminidase for restricting mycobacterial growth during mammalian infections is confirmed in macrophages from beta-hexosaminidase knockout mice. beta-Hexosaminidase is characterized as a peptidoglycan hydrolase that exerts its mycobactericidal effect at the macrophage plasma membrane during mycobacteria-induced secretion of lysosomes |
682592 |
1.3.1.24 | biliverdin reductase |
macrophage |
- |
673797, 698922, 740486, 740549 |
1.3.1.24 | biliverdin reductase |
macrophage |
increased expression in macrophages of primary spontaneous pneumothorax of smokers compared to non-smokers |
713359 |
1.3.1.24 | biliverdin reductase |
macrophage |
lung |
713359 |
2.6.1.42 | branched-chain-amino-acid transaminase |
macrophage |
- |
758657 |
1.14.15.18 | calcidiol 1-monooxygenase |
macrophage |
- |
675057, 675686 |
1.14.15.18 | calcidiol 1-monooxygenase |
macrophage |
expression of 1alpha-hydroxylase is intimately associated with toll-like receptor, TLR, recognition of pathogens in macrophages |
712885 |
1.14.15.18 | calcidiol 1-monooxygenase |
macrophage |
monocyte-derived |
688675 |
3.4.22.B26 | calpain 6 |
macrophage |
- |
754258 |
3.4.22.52 | calpain-1 |
macrophage |
- |
708717 |
3.4.22.53 | calpain-2 |
macrophage |
- |
717847 |
3.1.1.1 | carboxylesterase |
macrophage |
- |
691075 |
3.1.1.1 | carboxylesterase |
macrophage |
CES1, no expression of CES2 |
707570 |
3.4.17.1 | carboxypeptidase A |
macrophage |
in primary macrophages, CPVL is glycosylated with high mannose residues |
687160 |
3.4.16.5 | carboxypeptidase C |
macrophage |
of lung |
665905 |
3.4.17.12 | carboxypeptidase M |
macrophage |
- |
670291 |
3.4.17.12 | carboxypeptidase M |
macrophage |
CPM expression is the highest in macrophages |
697395 |
3.4.17.20 | Carboxypeptidase U |
macrophage |
- |
670940 |
3.4.22.36 | caspase-1 |
macrophage |
- |
-, 679079, 681017, 681030, 697733, 698235, 700198, 700362, 700983, 708709, 708712, 717941, 718077 |
3.4.22.36 | caspase-1 |
macrophage |
bone marrow-derived |
-, 698251, 699349 |
3.4.22.36 | caspase-1 |
macrophage |
bone marrow-derived macrophage, BMDM cell |
-, 697199, 698245 |
3.4.22.36 | caspase-1 |
macrophage |
bone marrow-derived macrophages, wild-type and superoxide dismutase-deficient |
700365 |
3.4.22.36 | caspase-1 |
macrophage |
bone-marrow derived |
670356 |
3.4.22.36 | caspase-1 |
macrophage |
bone-marrow-derived |
700393 |
3.4.22.36 | caspase-1 |
macrophage |
caspase-1-mediated macrophage necrosis is the source of the cytokine storm and rapid disease progression in anthrax lethal toxin-treated BALB/c mice |
679097 |
3.4.22.36 | caspase-1 |
macrophage |
IFN regulatory factor IRF-2(-/-) macrophages exhibit increased basal and gliotoxin-induced caspase-1 mRNA expression and enhanced caspase-1 activity |
681202 |
3.4.22.36 | caspase-1 |
macrophage |
inactive 45000 Da proform of caspase-1 is basally expressed in macrophages, virus infection induces the cleavage of procaspase into the mature 20000 Da form |
647636 |
3.4.22.36 | caspase-1 |
macrophage |
bone marrow derived. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Activation of caspase-1 by Bacillus anthracis lethal toxin requires binding, uptake, and endosome acidification to mediate translocation of lethal factor into the host cell cytosol. Catalytically active lethal factor cleaves cytosolic substrates and activates caspase-1 by a mechanism involving proteasome activity and potassium efflux. Lethal toxin activation of caspase-1 requires the inflammasome adapter Nalp1. Salmonella infection activates caspase-1 through an independent pathway requiring the inflammasome adapter Ipaf. These distinct mechanisms of caspase-1 activation converge on a common pathway of caspase-1-dependent cell death featuring DNA cleavage, cytokine activation, and, ultimately, cell lysis resulting from the formation of membrane pores between 1.1 and 2.4 nm in diameter and pathological ion fluxes that can be blocked by glycine |
682588 |
3.4.22.36 | caspase-1 |
macrophage |
macrophage-like J774.1 cells |
701307 |
3.4.22.36 | caspase-1 |
macrophage |
peritoneal |
698242 |
3.4.22.36 | caspase-1 |
macrophage |
the Gram-negative bacterium Shigella flexneri triggers pro-inflammatory apoptotic cell death in macrophages, which is crucial for the onset of an acute inflammatory diarrhoea termed bacillary dysentery. The Mxi-Spa type III secretion system promotes bacterial uptake and escape into the cytoplasm, where, dependent on the translocator/effector protein IpaB, caspase-1 and its substrate IL-1b are activated |
681799 |
3.4.22.36 | caspase-1 |
macrophage |
wild-type and TLR4 knockout macrophage |
699326 |
3.4.22.64 | caspase-11 |
macrophage |
- |
698218, 699327, 731744, 731905 |